BioPharmSignal logoBioPharmSignal

Biotech News

Acadia Healthcare Provides Notice of Proposed Derivative Action Settlement

Acadia Healthcare (ACHC)Acadia HealthcareFDA / regulatory

FRANKLIN, Tenn. --(BUSINESS WIRE)--Sep. 25, 2026-- Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) issues the below summary notice of proposed settlement as provided for in the September 1, 2026 order providing preliminary approval issued by the United States District

Related news

ACHCAcadia Healthcare2026-09-09 13:00 EST

Acadia Healthcare to Participate in 2026 Jefferies Healthcare Services and Technology Conference

ACHCAcadia Healthcare2026-07-28 20:05 EST

Acadia Healthcare Announces Second Quarter 2026 Results and Updates Full Year 2026 Financial and Cash Flow Guidance

ICCMIceCure Medical2026-09-10 11:58 EST

IceCure Medical Receives Regulatory Approval to Market ProSense® in China

ICUSeaStar Medical2026-10-07 12:16 EST

FDA Grants SeaStar Medical Breakthrough Device Designation for its SCD Therapy for the Treatment of Hyperinflammation in Adult Patients with Sepsis or a Septic Condition

JNJJohnson & Johnson2026-09-21 14:33 EST

European Commission approval of ICOTYDE™▼(icotrokinra) ushers in new era for first-line systemic treatment of plaque psoriasis with a targeted oral peptide

VTAKCatheter Precision2026-09-02 20:15 EST

Flyte Secures International Approval to Launch Private Aviation Service Across The Bahamas and Caribbean

ICCMIceCure Medical2026-08-20 12:10 EST

West Cancer Center Receives IRB Approval to Commence IceCure's ChoICE Study for Breast Cancer Cryoablation

JNJJohnson & Johnson2026-09-18 11:00 EST

CHMP recommends approval of Johnson & Johnson’s TECVAYLI®▼ (teclistamab) in relapsed/refractory multiple myeloma after at least one prior therapy

XAIRBeyond Air2026-08-31 12:00 EST

Beyond Air® Receives FDA Breakthrough Device Designation for LungFit® GO to Treat Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD)

FEMYFEMASYS2026-08-19 13:00 EST

Femasys Announces FDA Approval of Modular PMA Submission Approach for FemBloc®

View all latest news

Acadia Healthcare

Behavioral Healthcare Network Acadia Healthcare operates facilities that treat mental-health and substance-use disorders. Its network includes acute inpatient psychiatric hospitals, specialty treatment facilities and other behavioral-care settings. Inpatient and Specialty Care The company provides structured treatment for patients who...

Recent company news

ACHCAcadia Healthcare2026-09-25 20:05 EST

Acadia Healthcare Provides Notice of Proposed Derivative Action Settlement

ACHCAcadia Healthcare2026-09-09 13:00 EST

Acadia Healthcare to Participate in 2026 Jefferies Healthcare Services and Technology Conference

ACHCAcadia Healthcare2026-07-28 20:05 EST

Acadia Healthcare Announces Second Quarter 2026 Results and Updates Full Year 2026 Financial and Cash Flow Guidance

ACHCAcadia Healthcare2026-07-09 20:15 EST

Acadia Healthcare Announces Date for Second Quarter 2026 Earnings Release

ACHCAcadia Healthcare2026-04-29 20:05 EST

Acadia Healthcare Announces First Quarter 2026 Results

Stock data

Close
29.04 USD
Market cap
2.25B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States